Stockysis Logo
  • Login
  • Register
  • EN
    Translate page
    EN English ES Español FR Français DE Deutsch ZH 中文 AR العربية PT Português RU Русский JA 日本語 KO 한국어 HI हिन्दी IT Italiano
Back to News

CORRECTION: CVS Health Raises FY2026 Adj EPS Guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 Est; FY2026 Revenue expected to be more than $414.000B vs $409.235B Est

Benzinga Newsdesk www.benzinga.com Positive 90.6%
Neg 0% Neu 0% Pos 90.6%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Terms of Service Contact Us